136 related articles for article (PubMed ID: 9483563)
1. Binding of girisopam (a 2,3-benzodiazepine derivative) to the substantia nigra is prevented by lesioning of the striatonigral pathway.
Palkovits M; Lovas G; Horváth E
Neuroscience; 1998 Apr; 83(3):799-806. PubMed ID: 9483563
[TBL] [Abstract][Full Text] [Related]
2. Changes in specific binding sites of girisopam after chemical and surgical lesions in the striato-nigral system.
Horváth EJ; Fekete MI; Palkovits M
Brain Res Mol Brain Res; 1997 Apr; 45(1):141-4. PubMed ID: 9105681
[TBL] [Abstract][Full Text] [Related]
3. Denervation supersensitivity for benzodiazepine receptors in the rat substantia nigra.
Biggio G; Corda MG; Concas A; Gessa GL
Brain Res; 1981 Sep; 220(2):344-9. PubMed ID: 6269689
[TBL] [Abstract][Full Text] [Related]
4. Evidence that [3H]forskolin binding in the substantia nigra is intrinsic to a striatal-nigral projection: an autoradiographic study of rat brain.
Gehlert DR; Dawson TM; Filloux FM; Sanna E; Hanbauer I; Wamsley JK
Neurosci Lett; 1987 Jan; 73(2):114-8. PubMed ID: 3822243
[TBL] [Abstract][Full Text] [Related]
5. Neurotransmitter receptor localizations: brain lesion induced alterations in benzodiazepine, GABA, beta-adrenergic and histamine H1-receptor binding.
Chang RS; Tran VT; Snyder SH
Brain Res; 1980 May; 190(1):95-110. PubMed ID: 6103733
[TBL] [Abstract][Full Text] [Related]
6. Autoradiographic localization and quantitative determination of specific binding sites of anxiolytic homophthalazines (formerly called 2,3-benzodiazepines) in the striato-pallido-nigral system of rats.
Horváth EJ; Palkovits M; Lenkei Z; Gyüre KI; Fekete MI; Arányi P
Brain Res Mol Brain Res; 1994 Mar; 22(1-4):211-8. PubMed ID: 8015381
[TBL] [Abstract][Full Text] [Related]
7. Increase in nigral type II benzodiazepine recognition sites following striatonigral denervation.
Porceddu ML; Corda MG; Sanna E; Biggio G
Eur J Pharmacol; 1985 Jun; 112(2):265-7. PubMed ID: 2993000
[TBL] [Abstract][Full Text] [Related]
8. Localization of serotonin-4 receptors in the striatonigral pathway in rat brain.
Patel S; Roberts J; Moorman J; Reavill C
Neuroscience; 1995 Dec; 69(4):1159-67. PubMed ID: 8848104
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents.
Adachi K; Hasegawa M; Fujita S; Sato M; Miwa Y; Ikeda H; Koshikawa N; Cools AR
Eur J Pharmacol; 2002 May; 442(1-2):81-92. PubMed ID: 12020685
[TBL] [Abstract][Full Text] [Related]
10. Lesions of the globus pallidus, entopeduncular nucleus and substantia nigra alter dopamine mediated circling behaviour.
Dewar D; Jenner P; Marsden CD
Exp Brain Res; 1983; 52(2):281-92. PubMed ID: 6641888
[TBL] [Abstract][Full Text] [Related]
11. Functional changes in rat nigral GABA(A) receptors induced by degeneration of the striatonigral GABAergic pathway: an electrophysiological study of receptors incorporated into Xenopus oocytes.
Sanna E; Motzo C; Usala M; Pau D; Cagetti E; Biggio G
J Neurochem; 1998 Jun; 70(6):2539-44. PubMed ID: 9603220
[TBL] [Abstract][Full Text] [Related]
12. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
[TBL] [Abstract][Full Text] [Related]
13. Differential localization of type I and type II benzodiazepine binding sites in substantia nigra.
Lo MM; Niehoff DL; Kuhar MJ; Snyder SH
Nature; 1983 Nov 3-9; 306(5938):57-60. PubMed ID: 6314146
[TBL] [Abstract][Full Text] [Related]
14. Effect of discrete kainic acid-induced lesions of corpus caudatus and globus pallidus on glutamic acid decarboxylase of rat substantia nigra.
Di Chiara G; Morelli M; Porceddu ML; Mulas M; Del Fiacco M
Brain Res; 1980 May; 189(1):193-208. PubMed ID: 7363085
[TBL] [Abstract][Full Text] [Related]
15. Striato-nigral denervation increases type II benzodiazepine receptors in the substantia nigra of the rat.
Corda MG; Concas A; Porceddu ML; Sanna E; Biggio G
Neuropharmacology; 1986 Jan; 25(1):59-62. PubMed ID: 3005905
[TBL] [Abstract][Full Text] [Related]
16. Characterization of benzodiazepine receptor changes in substantia nigra, globus pallidus and entopeduncular nucleus after striatal lesions.
Pan HS; Penney JB; Young AB
J Pharmacol Exp Ther; 1984 Sep; 230(3):768-75. PubMed ID: 6147405
[TBL] [Abstract][Full Text] [Related]
17. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque.
Hedreen JC; DeLong MR
J Comp Neurol; 1991 Feb; 304(4):569-95. PubMed ID: 2013650
[TBL] [Abstract][Full Text] [Related]
18. Topography of substantia nigra innervation by D1 receptor-containing striatal neurons.
Altar CA; Hauser K
Brain Res; 1987 Apr; 410(1):1-11. PubMed ID: 2953407
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous topographical distribution of the striatonigral and striatopallidal neurons in the matrix compartment of the cat caudate nucleus.
Desban M; Gauchy C; Glowinski J; Kemel ML
J Comp Neurol; 1995 Jan; 352(1):117-33. PubMed ID: 7536221
[TBL] [Abstract][Full Text] [Related]
20. Glutamic acid decarboxylase (GAD) activity in the rat substantia nigra after discrete bilateral kainic acid-induced lesions of the caudate-putamen and globus pallidus: correlation with locomotor activity.
Al-Shabibi UM; Davies JA
Brain Res; 1981 Jun; 213(2):460-6. PubMed ID: 7248771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]